Galectin Therapeutics, Inc. (GALT)
3.62
-0.09
(-2.43%)
USD |
NASDAQ |
Oct 16, 16:00
3.63
+0.01
(+0.28%)
After-Hours: 20:00
Galectin Therapeutics Cash and Short Term Investments (Quarterly) : 13.27M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.27M |
| March 31, 2026 | 14.11M |
| December 31, 2025 | 17.72M |
| September 30, 2025 | 11.52M |
| June 30, 2025 | 13.77M |
| March 31, 2025 | 7.431M |
| December 31, 2024 | 15.12M |
| September 30, 2024 | 27.06M |
| June 30, 2024 | 25.60M |
| March 31, 2024 | 23.56M |
| December 31, 2023 | 25.66M |
| September 30, 2023 | 20.36M |
| June 30, 2023 | 17.97M |
| March 31, 2023 | 17.80M |
| December 31, 2022 | 18.59M |
| September 30, 2022 | 15.83M |
| June 30, 2022 | 24.18M |
| March 31, 2022 | 31.61M |
| December 31, 2021 | 39.65M |
| September 30, 2021 | 36.60M |
| June 30, 2021 | 31.60M |
| March 31, 2021 | 20.76M |
| December 31, 2020 | 27.14M |
| September 30, 2020 | 32.56M |
| June 30, 2020 | 40.77M |
| Date | Value |
|---|---|
| March 31, 2020 | 43.33M |
| December 31, 2019 | 47.48M |
| September 30, 2019 | 50.34M |
| June 30, 2019 | 52.04M |
| March 31, 2019 | 6.972M |
| December 31, 2018 | 8.253M |
| September 30, 2018 | 10.14M |
| June 30, 2018 | 10.50M |
| March 31, 2018 | 3.988M |
| December 31, 2017 | 3.059M |
| September 30, 2017 | 6.958M |
| June 30, 2017 | 9.127M |
| March 31, 2017 | 13.64M |
| December 31, 2016 | 15.37M |
| September 30, 2016 | 16.06M |
| June 30, 2016 | 18.00M |
| March 31, 2016 | 22.36M |
| December 31, 2015 | 25.85M |
| September 30, 2015 | 21.32M |
| June 30, 2015 | 26.36M |
| March 31, 2015 | 29.35M |
| December 31, 2014 | 29.13M |
| September 30, 2014 | 31.20M |
| June 30, 2014 | 34.42M |
| March 31, 2014 | 36.59M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 438.29M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |